Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/21/2003CA2066940C Canine coronavirus subunit vaccine
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085107A1 Cells with modified genome
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003085072A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes
10/16/2003WO2003084999A1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
10/16/2003WO2003084988A2 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084965A1 N-(3-rifamycinyl)-carbamates, method of preparing them and their use for treating and preventing tuberculosis
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084953A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003WO2003084950A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084947A1 4,5,6,7-tretrahydrobenzo[b] thiophene derivatives and methods for medical intervention against mycrobacterial infections
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084938A2 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003WO2003084937A2 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003WO2003084936A2 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
10/16/2003WO2003084935A2 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084571A1 Therapeutic composition for bone infectious disease
10/16/2003WO2003084570A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM
10/16/2003WO2003084569A1 Drug containing antibody composition
10/16/2003WO2003084568A2 Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations
10/16/2003WO2003084562A1 Chemokines mutants having improved oral bioavailability
10/16/2003WO2003084551A1 Agents for treating flaviviridae infections
10/16/2003WO2003084549A1 Hormone replacement therapy
10/16/2003WO2003084545A1 Drug containing riboflavin compound
10/16/2003WO2003084536A1 Oral administration of epothilones
10/16/2003WO2003084534A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003084517A2 Oral suspension of amoxicillin capsules
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003084462A2 Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability
10/16/2003WO2003070976A3 Methods for determining the influence of protein binding on antiretroviral activity
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003064595A3 Recombinant herpesvirus of turkeys and use thereof
10/16/2003WO2003063792A8 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/16/2003WO2003062443A3 Novel substituted alkane compounds and uses thereof
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003045414A3 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections
10/16/2003WO2003045335A3 Stem cell screening and transplantation therapy for hiv infection
10/16/2003WO2003041660A3 Solubilized topoisomerase poisons
10/16/2003WO2003037311A3 Method for treating retroviral infections
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003028634A3 Method of treatment using ligand-immunogen conjugates
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003020108A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003011314A3 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
10/16/2003WO2003010192A3 An inducer of apoptosis
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2002102307A3 Nucleoside vaccine adjuvants
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002072022A3 Substituted tetracycline compounds as antifungal agents
10/16/2003WO2002059606A3 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection
10/16/2003WO2002057313A3 Receptor-binding compounds and methods for identifying them
10/16/2003WO2002056898A3 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002042484A3 Method for producing pectin hydrolysis products
10/16/2003WO2002024307A3 Reducing the content of particular cell types in a biological sample
10/16/2003WO2002000166A3 New compounds useful as antibacterial agents
10/16/2003WO2001089527A3 Pharmaceutical composition comprising loratadine and a nasal decongestant
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030195365 CC-1065 analog synthesis
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195257 Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity
10/16/2003US20030195248 Novel approach to anti-microbial host defense with molecular shields with lipoxin compounds
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195228 Pharmaceutical compositions for hepatitis C viral protease inhibitors
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195225 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents
10/16/2003US20030195224 An immunomodulators, antitumor agents and induce cytokine biosynthesis, treating viral diseases
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
1 ... 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 ... 1798